Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.4K Sell
74
-1
-1% -$245 ﹤0.01% 492
2025
Q4
$19K Hold
75
﹤0.01% 474
2025
Q3
$18.5K Hold
75
﹤0.01% 432
2025
Q2
$17.9K Buy
75
+1
+1% +$233 ﹤0.01% 425
2025
Q1
$16.9K Sell
74
-10
-12% -$2.2K ﹤0.01% 420
2024
Q4
$17.4K Sell
84
-24,520
-100% -$5.38M ﹤0.01% 407
2024
Q3
$5.53M Sell
24,604
-920
-4% -$215K 0.8% 41
2024
Q2
$5.6M Buy
25,524
+769
+3% +$167K 0.77% 41
2024
Q1
$5.57M Buy
24,755
+552
+2% +$125K 0.8% 41
2023
Q4
$5.32M Buy
24,203
+1,159
+5% +$245K 0.86% 39
2023
Q3
$5.06M Buy
23,044
+1,567
+7% +$354K 0.92% 36
2023
Q2
$4.83M Buy
+21,477
New +$4.3M 0.85% 40

Other funds holding STE

Nemes Rush Group's STE Position: Q1 2026 in Review

Nemes Rush Group reduced its Steris (STE) stake by 1.3% in Q1 2026, selling an estimated $245 and leaving 74 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Nemes Rush Group first reported a position in STE in Q2 2023 and has held it in 12 quarters since. The position peaked at $5.6M in Q2 2024. 839 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Nemes Rush Group held 74 shares of Steris worth $16.4K as of Q1 2026.
  • Nemes Rush Group sold 1 Steris share in Q1 2026, an estimated $245.
  • Steris made up ﹤0.01% of Nemes Rush Group's portfolio in Q1 2026, its #492 holding.
  • Nemes Rush Group first reported a position in Steris in Q2 2023 and has held it in 12 quarters since.
  • Nemes Rush Group's Steris position peaked at $5.6M in Q2 2024.
  • 839 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.